Brookstone Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.62M Sell
18,060
-2,526
-12% -$622K 0.05% 341
2026
Q2
$3.85M Buy
20,586
+4,844
+31% +$891K 0.04% 369
2026
Q1
$2.97M Buy
15,742
+291
+2% +$61.3K 0.03% 398
2025
Q4
$3.07M Sell
15,451
-681
-4% -$138K 0.04% 380
2025
Q3
$3.28M Buy
16,132
+3,278
+26% +$582K 0.04% 372
2025
Q2
$2.26M Sell
12,854
-1,428
-10% -$215K 0.03% 402
2025
Q1
$1.92M Buy
+14,282
New +$1.88M 0.03% 418
2022
Q1
– Sell
-100
Closed -$7K – 852
2021
Q4
$7K Buy
+100
New +$7.31K ﹤0.01% 747

Other funds holding THC

Brookstone Capital Management's THC Position: Q3 2026 in Review

Brookstone Capital Management reduced its Tenet Healthcare (THC) stake by 12% in Q3 2026, selling an estimated $622K and leaving 18,060 shares worth $4.62M. The position accounts for 0.05% of the portfolio, ranked #341.

Brookstone Capital Management first reported a position in THC in Q4 2021 and has held it in 8 quarters since. 157 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Brookstone Capital Management held 18,060 shares of Tenet Healthcare worth $4.62M as of Q3 2026.
  • Brookstone Capital Management sold 2,526 Tenet Healthcare shares in Q3 2026, an estimated $622K.
  • Tenet Healthcare made up 0.05% of Brookstone Capital Management's portfolio in Q3 2026, its #341 holding.
  • Brookstone Capital Management first reported a position in Tenet Healthcare in Q4 2021 and has held it in 8 quarters since.
  • 157 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Brookstone Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.